BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen P, Wang M, Wang C. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals. Biosci Rep 2019;39:BSR20190610. [PMID: 31147453 DOI: 10.1042/BSR20190610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim A, Ha J, Kim J, Cho Y, Ahn J, Cheon C, Kim SH, Ko SG, Kim B. Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. Nutrients 2021;13:3801. [PMID: 34836055 DOI: 10.3390/nu13113801] [Reference Citation Analysis]
2 Yin QH, Zhou Y, Li ZHY. miR-373 Suppresses Cell Proliferation and Apoptosis via Regulation of SIRT1/PGC-1α/NRF2 Axis in Pancreatic Cancer. Cell J 2021;23:199-210. [PMID: 34096221 DOI: 10.22074/cellj.2021.7038] [Reference Citation Analysis]
3 Grubelnik G, Boštjančič E, Aničin A, Dovšak T, Zidar N. MicroRNAs and Long Non-Coding RNAs as Regulators of NANOG Expression in the Development of Oral Squamous Cell Carcinoma. Front Oncol 2020;10:579053. [PMID: 33643897 DOI: 10.3389/fonc.2020.579053] [Reference Citation Analysis]
4 Liu W, Yu C, Li J, Fang J. The Roles of EphB2 in Cancer. Front Cell Dev Biol 2022;10:788587. [DOI: 10.3389/fcell.2022.788587] [Reference Citation Analysis]
5 Qian X, Chen Z, Chen SS, Liu LM, Zhang AQ. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network. J Immunol Res 2020;2020:7503605. [PMID: 32537471 DOI: 10.1155/2020/7503605] [Cited by in F6Publishing: 1] [Reference Citation Analysis]